|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2006-3-15
|
|
pubmed:abstractText |
Misfolded proteins accumulate in many neurodegenerative diseases, including huntingtin in Huntington's disease and alpha-synuclein in Parkinson's disease. The disease-causing proteins can take various conformations and are prone to aggregate and form larger cytoplasmic or nuclear inclusions. One approach to the development of therapeutic intervention for these diseases has been to identify chemical compounds that reduce the size or number of inclusions. We have, however, identified a compound that promotes inclusion formation in cellular models of both Huntington's disease and Parkinson's disease. Of particular interest, this compound prevents huntingtin-mediated proteasome dysfunction and reduces alpha-synuclein-mediated toxicity. These results demonstrate that compounds that increase inclusion formation may actually lessen cellular pathology in both Huntington's and Parkinson's diseases, suggesting a therapeutic approach for neurodegenerative diseases caused by protein misfolding.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-11331615,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-11375494,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-11395418,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-11440819,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-11917093,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-11932737,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-12374759,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-12421356,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-12651870,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-12702875,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-12730384,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-14593171,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-15044495,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-15068806,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-15470501,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-15483602,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-15564047,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-15694337,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-8078881,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-8873613,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-8942653,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-9197268,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16537516-9582269
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Recombinant,
http://linkedlifedata.com/resource/pubmed/chemical/Green Fluorescent Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/HD protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Piperazines,
http://linkedlifedata.com/resource/pubmed/chemical/Proteasome Endopeptidase Complex,
http://linkedlifedata.com/resource/pubmed/chemical/Quinolines,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-Synuclein,
http://linkedlifedata.com/resource/pubmed/chemical/enhanced green fluorescent protein
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0027-8424
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
14
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4246-51
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16537516-Amino Acid Sequence,
pubmed-meshheading:16537516-Animals,
pubmed-meshheading:16537516-Base Sequence,
pubmed-meshheading:16537516-CHO Cells,
pubmed-meshheading:16537516-Cell Line,
pubmed-meshheading:16537516-Cricetinae,
pubmed-meshheading:16537516-DNA, Recombinant,
pubmed-meshheading:16537516-Genes, Reporter,
pubmed-meshheading:16537516-Green Fluorescent Proteins,
pubmed-meshheading:16537516-Humans,
pubmed-meshheading:16537516-Huntington Disease,
pubmed-meshheading:16537516-Inclusion Bodies,
pubmed-meshheading:16537516-Nerve Tissue Proteins,
pubmed-meshheading:16537516-Nuclear Proteins,
pubmed-meshheading:16537516-Parkinson Disease,
pubmed-meshheading:16537516-Piperazines,
pubmed-meshheading:16537516-Proteasome Endopeptidase Complex,
pubmed-meshheading:16537516-Protein Folding,
pubmed-meshheading:16537516-Quinolines,
pubmed-meshheading:16537516-Recombinant Fusion Proteins,
pubmed-meshheading:16537516-alpha-Synuclein
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases.
|
|
pubmed:affiliation |
Center for Cancer Research, Massachusetts Institute of Technology, Room E18-505, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
|
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
